GlassScriptPhysician profile
Kristen Scholl
NPI 1164859831
$1,191.75
in general payments reported to CMS, 2019-2025
21 companies · $521 in 2025
The $521 reported for 2025 was more than what 81% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $44.93 · 2022: $238 · 2023: $96.30 · 2024: $291 · 2025: $521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $908.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $908.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $521.84 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $90.82 | 2022-2023 | Entyvio |
| Pfizer INC. | $68.44 | 2024-2025 | |
| Hologic Sales and Service, LLC | $61.11 | 2025 | Myosure Tissue Removal Device, Aptima |
| Exact Sciences Corporation | $56.29 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Astellas Pharma US INC | $48.19 | 2025 | Veozah |
| Janssen Biotech, INC. | $45.86 | 2022 | |
| Ethicon US, LLC | $44.93 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.22 | 2022 | |
| Novo Nordisk INC | $29.19 | 2024 | Wegovy |
| Celgene Corporation | $26.73 | 2022 | |
| Csl Behring | $24.05 | 2023 | Kcentra |
| Ucb, INC. | $18.95 | 2022 | |
| Exeltis, USA INC. | $18.05 | 2024 | Slynd |
| Smith+Nephew, INC. | $17.50 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $17.04 | 2022 | |
| Lilly USA, LLC | $15.93 | 2025 | Zepbound, Mounjaro |
| Nestle Healthcare Nutrition INC. | $15.21 | 2023 | |
| Endo Pharmaceuticals INC. | $14.84 | 2022 | |
| Axsome Therapeutics, INC. | $14.49 | 2025 | Auvelity |
| Channel Medsystems, INC. | $11.07 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristen Scholl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.